Healthy Skepticism Library item: 7923

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Wechsler J.
DTC dilemma
Pharmaceutical Executive 1999 Nov; 19:22, 24, 26-27

Abstract:

The positive and negative impact of direct to consumer (DTC) prescription drug advertising, including increased prescription costs, U.S. Food and Drug Administration (FDA) guidance, First Amendment issues, risks of off label claims, and the need to exercise caution about promotional claims, is discussed.